Premature Births

Also known as: PreTerm Birth / Premature Birth / Birth premature / Premature birth, NOS / Early onset of delivery / Premature delivery / Premature baby / Baby premature / Immature baby / 28 completed weeks or more but less than 37 completed weeks (196 completed days but less than 259 completed days) of gestation. / Prematurity / Infant premature

DrugDrug NameDrug Description
DB06761BeractantBeractant is a pulmonary surfactant used for the treatment of Respiratory Distress Syndrome (RDS) in premature infants. Considered a natural source of surfactant as it is made from bovine lung extract, beractant contains a mixture of phospholipids, neutral lipids, fatty acids, and surfactant-associated proteins such as SP-B and SP-C. The final composition provides 25 mg/mL phospholipids (including 11.0-15.5 mg/mL disaturated phosphatidylcholine), 0.5-1.75 mg/mL triglycerides, 1.4-3.5 mg/mL free fatty acids, and less than 1.0 mg/mL protein. It is suspended in 0.9% sodium chloride solution, and heat-sterilized. In anticipation of birth, endogenous lung surfactant is produced to lower the surface tension on alveolar surfaces and to stabilize the alveoli against collapse at resting transpulmonary pressures. However, in Respiratory Distress Syndrome, developmental deficiency of surfactant results collapse of the alveoli causing fast breathing, increased heart rate, apoxia, and sometimes death. Administration of lung surfactant remains the cornerstone of therapy in this condition that is currently the leading cause of death in preterm infants. In comparison to synthetic forms of surfacant, natural forms such as Beractant have been found to have a reduced incidence of pneumothorax and reduced mortality.
DB06789Hydroxyprogesterone caproateHydroxyprogesterone caproate is a synthetic steroid hormone that is similar to medroxyprogesterone acetate and megestrol acetate. It is an ester derivative of 17α-hydroxyprogesterone formed from caproic acid (hexanoic acid). Hydroxyprogesterone caproate was previously marketed under the trade name Delalutin by Squibb, which was approved by the U.S. Food and Drug Administration (FDA) in 1956 and withdrawn from marketing in 1999. The U.S. FDA approved Makena from KV Pharmaceutical (previously named as Gestiva) on February 4, 2011 for prevention of preterm delivery in women with a history of preterm delivery, sparking a pricing controversy.
DB01050IbuprofenIbuprofen is a non-steroidal anti-inflammatory drug (NSAID) derived from propionic acid and it is considered the first of the propionics.[A39074] The formula of ibuprofen is 2-(4-isobutylphenyl) propionic acid and its initial development was in 1960 while researching for a safer alternative for aspirin.[A39075] Ibuprofen was finally patented in 1961 and this drug was first launched against rheumatoid arthritis in the UK in 1969 and USA in 1974. It was the first available over-the-counter NSAID.[A39076] On the available products, ibuprofen is administered as a racemic mixture. Once administered, the R-enantiomer undergoes extensive interconversion to the S-enantiomer _in vivo_ by the activity of the alpha-methylacyl-CoA racemase. In particular, it is generally proposed that the S-enantiomer is capable of eliciting stronger pharmacological activity than the R-enantiomer.[A39194]
DB09113Poractant alfaPoractant alfa is a pulmonary surfactant marketed as Curosurf in the United States and Canada. It is used to treat Respiratory Distress Syndrome (RDS) in premature infants with an endogenous pulmonary surfactant deficiency. Poractant alfa is an extract of natural porcine lung surfactant consisting of 99% polar lipids (mainly phospholipids) and 1% hydrophobic low molecular weight proteins (surfactant associated proteins SP-B and SP-C). The phospholipid content of the extract consists primarily of phosphatidylcholine and dipaImitoylphosphatidylcholine. Poractant alfa is a creamy white suspension of this extract in 0.9% sodium chloride solution. It contains no preservatives.
DrugDrug NameTargetType
DB06789Hydroxyprogesterone caproateProgesterone receptortarget
DB06789Hydroxyprogesterone caproateCytochrome P450 3A4enzyme
DB06789Hydroxyprogesterone caproateCytochrome P450 3A5enzyme
DB06789Hydroxyprogesterone caproateCytochrome P450 2C19enzyme
DB01050IbuprofenProstaglandin G/H synthase 1target
DB01050IbuprofenProstaglandin G/H synthase 2target
DB01050IbuprofenCytochrome P450 2C9enzyme
DB01050IbuprofenSerum albumincarrier
DB01050IbuprofenMultidrug resistance-associated protein 4transporter
DB01050IbuprofenMultidrug resistance-associated protein 1transporter
DB01050IbuprofenSolute carrier organic anion transporter family member 1A2transporter
DB01050IbuprofenSolute carrier family 22 member 6transporter
DB01050IbuprofenSolute carrier family 22 member 8transporter
DB01050IbuprofenSolute carrier family 22 member 11transporter
DB01050IbuprofenSolute carrier organic anion transporter family member 2B1transporter
DB01050IbuprofenMultidrug resistance protein 1transporter
DB01050IbuprofenUDP-glucuronosyltransferase 1-3enzyme
DB01050IbuprofenUDP-glucuronosyltransferase 1-9enzyme
DB01050IbuprofenUDP-glucuronosyltransferase 2B4enzyme
DB01050IbuprofenUDP-glucuronosyltransferase 2B7enzyme
DB01050IbuprofenCytochrome P450 2C8enzyme
DB01050IbuprofenCytochrome P450 2C19enzyme
DB01050IbuprofenApoptosis regulator Bcl-2target
DB01050IbuprofenFatty acid-binding protein, intestinaltarget
DB01050IbuprofenPeroxisome proliferator-activated receptor gammatarget
DB01050IbuprofenCystic fibrosis transmembrane conductance regulatortarget
DB01050IbuprofenPeroxisome proliferator-activated receptor alphatarget
DB01050IbuprofenPlatelet glycoprotein Ib alpha chaintarget
DB01050IbuprofenProtein S100-A7target
DB01050IbuprofenAlpha-methylacyl-CoA racemaseenzyme
DrugDrug NamePhaseStatusCount
DB00653Magnesium sulfate0Completed1
DB00443Betamethasone1Active Not Recruiting1
DB01234Dexamethasone1Active Not Recruiting1
DB00945Acetylsalicylic acid2Completed1
DB00328Indometacin2Unknown Status1
DB01234Dexamethasone2 / 3Recruiting1
DB00378Dydrogesterone2 / 3Recruiting1
DB06789Hydroxyprogesterone caproate2 / 3Recruiting1
DB01065Melatonin2 / 3Terminated1
DB00110Palivizumab2 / 3Completed1
DB00396Progesterone2 / 3Not Yet Recruiting1
DB00396Progesterone2 / 3Recruiting1
DB00396Progesterone2 / 3Withdrawn1
DB00443Betamethasone3Active Not Recruiting1
DB06789Hydroxyprogesterone caproate3Active Not Recruiting1
DB01378Magnesium cation3Recruiting1
DB11110Magnesium citrate3Recruiting1
DB00396Progesterone3Not Yet Recruiting1
DB00396Progesterone3Unknown Status1
DB09153Sodium chloride3Unknown Status1
DB00945Acetylsalicylic acid4Completed1
DB06755Beta carotene4Completed1
DB09341Dextrose, unspecified form4Completed1
DB03756Doconexent4Active Not Recruiting1
DB06789Hydroxyprogesterone caproate4Recruiting1
DB01378Magnesium cation4Completed1
DB00435Nitric Oxide4Completed1
DB00162Vitamin A4Completed1
DB11175Zinc picolinate4Completed1
DB00945Acetylsalicylic acidNot AvailableActive Not Recruiting1
DB09059AtosibanNot AvailableActive Not Recruiting1
DB00653Magnesium sulfateNot AvailableTerminated1
DB01115NifedipineNot AvailableTerminated1
DB00396ProgesteroneNot AvailableCompleted3
DB00396ProgesteroneNot AvailableNot Yet Recruiting1
DB00396ProgesteroneNot AvailableRecruiting2
DB00396ProgesteroneNot AvailableTerminated1
DB00396ProgesteroneNot AvailableWithdrawn2